[1]
“A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial: Midodrine and refractory gastroesophageal disease”, Acta Biomed, vol. 91, no. 1, pp. 70–78, Mar. 2020, doi: 10.23750/abm.v91i1.8486.